Integer Holdings Corporation
ITGR
Peringkat dalam Saham
#3837
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Harga Saham
$126.75
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$4.31B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
18.05%
Negara
US
Perdagangan Integer Holdings Corporation (ITGR)
Kategori
Healthcare
Rasio P/E untuk Integer Holdings Corporation (ITGR)
Rasio P/E per October 2026 TTM: 34.31
Menurut laporan keuangan dan harga saham terbaru dari Integer Holdings Corporation, rasio P/E saat ini (TTM) adalah 34.31. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar 36.42.
Riwayat rasio P/E untuk Integer Holdings Corporation dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 34.31 | -7.62% |
| 2024 | 37.14 | 1.98% |
| 2023 | 36.42 | 6.59% |
| 2022 | 34.17 | 17.13% |
| 2021 | 29.17 | -15.49% |
| 2020 | 34.52 | 26.71% |
| 2019 | 27.24 | 87.26% |
| 2018 | 14.55 | -31.81% |
| 2017 | 21.33 | -85.97% |
| 2016 | 152.06 | 598.09% |
| 2015 | 21.78 | -24.82% |
| 2014 | 28.97 | -125.76% |
| 2012 | -112.49 | -824.88% |
| 2011 | 15.52 | -7.70% |
| 2010 | 16.81 | -48.10% |
| 2009 | 32.39 | 10.54% |
| 2007 | 29.31 | -19.48% |
| 2006 | 36.40 | -34.47% |
| 2005 | 55.54 | 88.56% |
| 2004 | 29.45 | -29.19% |
| 2003 | 41.59 | -49.94% |
| 2001 | 83.08 | -111.38% |
| 2000 | -730.32 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 33.11 | -3.50% |
US
|
|
| 21.39 | -37.67% |
IE
|
|
| 28.94 | -15.64% |
US
|
|
| 17.34 | -49.47% |
US
|
|
| - | - |
DE
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.